Sacramento selected as COVID-19 vaccine trial site

Sacramento has been selected as a site for a COVID-19 vaccine trial. Both UC Davis Medical Center and Kaiser Permanente are participating in the vaccine trial through a partnership with Pfizer. The trial will span 120 locations with a goal of including 30,000 applicants worldwide. Get the full story in the video above.